The novel treatment of this peptide represents a major development in the management of the condition. Different to existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatide-peptide882587.rimmablog.com/40708994/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment